Clinical Trials Browser

Phase 2 × Crizotinib × Tumor-Agnostic × Clear all

NCT02034981 2024-02-28

AcSé

Phase 2 Completed

Neoplasm Metastasis

NCT02925234 2024-01-24

DRUP

Phase 2 Recruiting

Neoplasms

NCT02142036 2019-03-13

MetAction

Phase 2 Completed

Neoplasm Metastasis